FindTrial
Sign In

Comparison of antiepileptic drugs in terms of their effect on quality of life and cost of treatment in person with epilepsy

Comparison of newer and conventional antiepileptic drugs in focal and generalized seizures in terms of quality of life and cost of treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/009997
Enrollment
292
Registered
2017-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Persons with epilepsy on antiepileptic drug therapy

Interventions

None listed

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Persons with epilepsy (PWE) diagnosed clinically Age more than 18 years, either male or female PWE with either partial or generalized seizures PWE on monotherapy of newer (e.g. levetiracetam) or conventional (e.g. valproate, carbamazepine, phenytoin) antiepileptic drugs

Exclusion criteria

Exclusion criteria: Persons not willing to give informed consent Persons on AED polytherapy. Persons having any psychiatric disorder Persons having any other neurological or chronic disease except epilepsy

Design outcomes

Primary

MeasureTime frame
To compare the quality of life based on QOLIE-10-P scale during 6 months follow up between newer and conventional antiepileptic drugs administered as monotherapy to persons with epilepsy having partial and generalized seizures.Timepoint: 6 months follow up—

Secondary

MeasureTime frame
To compare cost of treatment ( based on cost of drugs, efficacy, expense on laboratory investigations ,adverse drug effect, other quality of life parameters) during 6 months follow up between newer and conventional antiepileptic drugs administered as monotherapy to persons with epilepsy having partial and generalized seizures.Timepoint: 6 months follow up—

Countries

India

Contacts

Public ContactProf Manjari Tripathi

All India Institute of Medical Sciences, New Delhi

niven103@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026